Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126409331 | 12640933 | 1 | I | 2016 | 20160802 | 20160810 | 20160810 | EXP | US-GLAXOSMITHKLINE-US2016112288 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126409331 | 12640933 | 1 | PS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | R759397 | 204275 | 1 | DF | INHALATION POWDER | QD | |||||
| 126409331 | 12640933 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 5ZP9006 | 0 | 1 | DF | INHALATION POWDER | BID | ||||
| 126409331 | 12640933 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 126409331 | 12640933 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | U | 0 | |||||||||||
| 126409331 | 12640933 | 5 | C | CLARITIN | LORATADINE | 1 | U | 0 | |||||||||||
| 126409331 | 12640933 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 126409331 | 12640933 | 7 | C | METOPROLOL. | METOPROLOL | 1 | U | 0 | |||||||||||
| 126409331 | 12640933 | 8 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126409331 | 12640933 | 1 | Asthma |
| 126409331 | 12640933 | 2 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126409331 | 12640933 | HO |
| 126409331 | 12640933 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126409331 | 12640933 | Atrial fibrillation | |
| 126409331 | 12640933 | Diverticulitis | |
| 126409331 | 12640933 | Dysphagia | |
| 126409331 | 12640933 | Dysphonia | |
| 126409331 | 12640933 | Dyspnoea | |
| 126409331 | 12640933 | Erosive oesophagitis | |
| 126409331 | 12640933 | Gastrooesophageal reflux disease | |
| 126409331 | 12640933 | Malaise | |
| 126409331 | 12640933 | Nodule | |
| 126409331 | 12640933 | Oropharyngeal pain | |
| 126409331 | 12640933 | Pneumonia | |
| 126409331 | 12640933 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126409331 | 12640933 | 1 | 2014 | 0 | ||
| 126409331 | 12640933 | 2 | 2005 | 0 | ||
| 126409331 | 12640933 | 3 | 2007 | 0 |